MapTrek to Increase Activity Among Patients at Risk for Type 2 Diabetes

MapTrek, an Interactive, m-Health Intervention to Increase Activity Among Patients at Risk for Type 2 Diabetes

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03193229

Enrollment

430

Registered

2017-06-20

Start date

2017-05-15

Completion date

2018-05-04

Last updated

2018-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Pre Diabetes

Brief summary

The overarching objective of our work is to provide an inexpensive and scalable m-health tool to increase both volume and intensity of physical activity and reduce sedentary behavior in patients at risk for type 2 diabetes. The objective of this study is to pilot test MapTrek, a text-messaging based intervention.

Detailed description

This study will randomize participants to 2 groups, an intervention group that will receive a Fitbit and MapTrek, and a control group that will receive a Fitbit only. This study has 3 specific aims. Aim 1- To determine if patients randomized to MapTrek walk more than the control patients. Aim 2- To determine if patients randomized to MapTrek generally walk at a faster pace during the day than control patients. Aim 3- To determine if patients randomized to MapTrek have less sedentary time during the day than the control patients. We expect to collect sufficient data to demonstrate the effectiveness of MapTrek, our prototype m-health tool, as an intervention to increase physical activity, heighten intensity of activity, and reduce sedentary behavior among a cohort of patients at risk for type 2 diabetes.

Interventions

BEHAVIORALMapTrek

The objective of the study is to provide an inexpensive and scalable m-health tool to increase both volume and intensity of physical activity and reduce sedentary behavior in patients at risk for or already diagnosed with pre-diabetes.

DEVICEFitbit

Fitbit

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

21 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* At least 21 years old * English speaker * Have a smart phone with texting and internet capabilities * No aversion to research studies * No active mental health conditions * 1\) Have a BMI \> or equal to 25 and a history of hemoglobin A1C level between 5.7 and 6.4%, or 2) have a BMI \> or equal to 30.

Exclusion criteria

* Pregnancy * Prisoner status * Taking insulin or other diabetic medications

Design outcomes

Primary

Measure	Time frame	Description
Total number of steps per day	6 months	The Fitbit will provide the total number of steps that each patient has taken per day.

Secondary

Measure	Time frame	Description
Pace of steps per day	6 months	The Fitbit will provide the number of steps taken per minute (pace) per day.

Other

Measure	Time frame	Description
Sedentary minutes per day	6 months	The Fitbit will provide the number of minutes spent being sedentary per day.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026